On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
parallel group
.
Show all posts
Showing posts with label
parallel group
.
Show all posts
Saturday, September 28, 2024
Crossover design in confirmatory therapeutic trials
›
This week, FDA approved a new drug called Aqneursa (levacetylleucine) for the treatment of neurological symptoms associated with Niemann-Pi...
›
Home
View web version
